2024-12-27 11:44:17
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy
Corporate/ 2023-07-23
OliX Announces Clinical Candidate Nomina...

SUWON,South Korea,Jan. 18,2019-- OLX10020,a cell-penetrating asymmetric siRNA ("cp-asiRNA") against a novel target (Undisclosed) f...

Cell Therapy Market to Grow Beyond Oncology As Big Pharma Expands Investments
Health/ 2023-07-22
Cell Therapy Market to Grow Beyond Oncol...

Collaborative business approach and adoption of value-based pricing models will create growth opportunities,finds Frost & Sullivan

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release